Improving Patient Quality Of Life: Soligenix Progresses Treatment For Painful Ulcers Associated With Rare Behcet's Disease 21.02.2025 / 15:04 CET/CEST The issuer is solely responsible for the content ...

Indications of the disease within individuals usually include mouth sores, skin rashes and lesions, genital sores, leg ulcers and eye inflammation, with inflammation of the joints observed in the ...

(NASDAQ: SNGX), a late-stage biopharmaceutical company focused on developing and commercializing products to treat rare diseases and areas of unmet medical need, is utilizing its pharmaceutical ...

genital and skin ulcer flares in Behçet's Disease. The launch of the phase 2 clinical trial of SGX945 is a milestone moment for Soligenix. As the firm progresses in treating Behcet's Disease and ...

Soligenix (NASDAQ:SNGX – Get Free Report) is anticipated to post its quarterly earnings results before the market opens on ...

Soligenix (NASDAQ:SNGX – Get Free Report) is expected to be announcing its earnings results before the market opens on ...

genital ulcers and uveitis. Subsequent observations, however, showed that the syndrome also included articular, gastrointestinal, central nervous system (CNS) and peripheral vascular manifestations.

Although it may affect almost all/any systems or organs, the key clinical manifestations are recurrent oral aphthous ulcers, genital ulcers, uveitis and skin lesions. Although most prevalent along ...

Although BD may affect almost any system of the body with exacerbations and remissions of inflammation, the key clinical manifestations are recurrent oral aphthous ulcers, genital ulcers ...

The United States Cutaneous Lymphoma Consortium is a multidisciplinary society of physicians which use collaborative research and education to improve the quality of life and prognosis of patients ...